Logo image of JBTM

JBT MAREL CORP (JBTM) Stock Fundamental Analysis

USA - NYSE:JBTM - US4778391049 - Common Stock

137.53 USD
-3.27 (-2.32%)
Last: 11/13/2025, 8:04:00 PM
137.53 USD
0 (0%)
After Hours: 11/13/2025, 8:04:00 PM
Fundamental Rating

3

Overall JBTM gets a fundamental rating of 3 out of 10. We evaluated JBTM against 130 industry peers in the Machinery industry. JBTM has a bad profitability rating. Also its financial health evaluation is rather negative. JBTM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

JBTM had positive earnings in the past year.
JBTM had a positive operating cash flow in the past year.
JBTM had positive earnings in each of the past 5 years.
JBTM had a positive operating cash flow in each of the past 5 years.
JBTM Yearly Net Income VS EBIT VS OCF VS FCFJBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

With a Return On Assets value of -1.35%, JBTM is not doing good in the industry: 73.85% of the companies in the same industry are doing better.
With a Return On Equity value of -2.50%, JBTM is not doing good in the industry: 73.08% of the companies in the same industry are doing better.
JBTM has a worse Return On Invested Capital (1.95%) than 69.23% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JBTM is below the industry average of 10.28%.
Industry RankSector Rank
ROA -1.35%
ROE -2.5%
ROIC 1.95%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
JBTM Yearly ROA, ROE, ROICJBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

In the last couple of years the Profit Margin of JBTM has declined.
JBTM has a Operating Margin of 4.81%. This is in the lower half of the industry: JBTM underperforms 63.85% of its industry peers.
JBTM's Operating Margin has declined in the last couple of years.
JBTM has a better Gross Margin (35.80%) than 66.15% of its industry peers.
JBTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.81%
PM (TTM) N/A
GM 35.8%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
JBTM Yearly Profit, Operating, Gross MarginsJBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JBTM is destroying value.
JBTM has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for JBTM has been increased compared to 5 years ago.
JBTM has a worse debt/assets ratio than last year.
JBTM Yearly Shares OutstandingJBTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
JBTM Yearly Total Debt VS Total AssetsJBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 1.85 indicates that JBTM is not a great score, but indicates only limited risk for bankruptcy at the moment.
JBTM's Altman-Z score of 1.85 is on the low side compared to the rest of the industry. JBTM is outperformed by 67.69% of its industry peers.
JBTM has a debt to FCF ratio of 6.97. This is a slightly negative value and a sign of low solvency as JBTM would need 6.97 years to pay back of all of its debts.
With a Debt to FCF ratio value of 6.97, JBTM perfoms like the industry average, outperforming 46.92% of the companies in the same industry.
A Debt/Equity ratio of 0.43 indicates that JBTM is not too dependend on debt financing.
The Debt to Equity ratio of JBTM (0.43) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.97
Altman-Z 1.85
ROIC/WACC0.22
WACC8.99%
JBTM Yearly LT Debt VS Equity VS FCFJBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

JBTM has a Current Ratio of 0.93. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.93, JBTM is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
JBTM has a Quick Ratio of 0.93. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.53, JBTM is doing worse than 90.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.53
JBTM Yearly Current Assets VS Current LiabilitesJBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

JBTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.08%, which is quite impressive.
The Earnings Per Share has been growing slightly by 0.52% on average over the past years.
The Revenue has grown by 92.43% in the past year. This is a very strong growth!
Measured over the past years, JBTM shows a decrease in Revenue. The Revenue has been decreasing by -2.48% on average per year.
EPS 1Y (TTM)27.08%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%29.33%
Revenue 1Y (TTM)92.43%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%120.65%

3.2 Future

Based on estimates for the next years, JBTM will show a very strong growth in Earnings Per Share. The EPS will grow by 22.75% on average per year.
The Revenue is expected to grow by 4.83% on average over the next years.
EPS Next Y17.72%
EPS Next 2Y21.12%
EPS Next 3Y22.75%
EPS Next 5YN/A
Revenue Next Year113.32%
Revenue Next 2Y49.55%
Revenue Next 3Y33%
Revenue Next 5Y4.83%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
JBTM Yearly Revenue VS EstimatesJBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
JBTM Yearly EPS VS EstimatesJBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 22.55, which indicates a rather expensive current valuation of JBTM.
JBTM's Price/Earnings ratio is in line with the industry average.
JBTM's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.91.
Based on the Price/Forward Earnings ratio of 18.38, the valuation of JBTM can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of JBTM is on the same level as its industry peers.
JBTM is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.55
Fwd PE 18.38
JBTM Price Earnings VS Forward Price EarningsJBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JBTM is valued a bit more expensive than the industry average as 66.92% of the companies are valued more cheaply.
The rest of the industry has a similar Price/Free Cash Flow ratio as JBTM.
Industry RankSector Rank
P/FCF 26.13
EV/EBITDA 23
JBTM Per share dataJBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as JBTM's earnings are expected to grow with 22.75% in the coming years.
PEG (NY)1.27
PEG (5Y)43.55
EPS Next 2Y21.12%
EPS Next 3Y22.75%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.28%, JBTM is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.86, JBTM has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, JBTM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.28%

5.2 History

The dividend of JBTM has a limited annual growth rate of 0.48%.
JBTM has been paying a dividend for over 5 years, so it has already some track record.
JBTM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.48%
Div Incr Years0
Div Non Decr Years4
JBTM Yearly Dividends per shareJBTM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

The earnings of JBTM are negative and hence is the payout ratio. JBTM will probably not be able to sustain this dividend level.
The dividend of JBTM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-17.36%
EPS Next 2Y21.12%
EPS Next 3Y22.75%
JBTM Yearly Income VS Free CF VS DividendJBTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

JBT MAREL CORP

NYSE:JBTM (11/13/2025, 8:04:00 PM)

After market: 137.53 0 (0%)

137.53

-3.27 (-2.32%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)05-04 2026-05-04
Inst Owners92.99%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner Change3.95%
Market Cap7.15B
Revenue(TTM)3.26B
Net Income(TTM)-110.60M
Analysts80
Price Target147.7 (7.39%)
Short Float %6.17%
Short Ratio5.74
Dividend
Industry RankSector Rank
Dividend Yield 0.28%
Yearly Dividend0.41
Dividend Growth(5Y)0.48%
DP-17.36%
Div Incr Years0
Div Non Decr Years4
Ex-Date08-18 2025-08-18 (0.1)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.24%
Min EPS beat(2)14.08%
Max EPS beat(2)26.4%
EPS beat(4)3
Avg EPS beat(4)11.49%
Min EPS beat(4)-8.58%
Max EPS beat(4)26.4%
EPS beat(8)5
Avg EPS beat(8)4.11%
EPS beat(12)9
Avg EPS beat(12)6.09%
EPS beat(16)11
Avg EPS beat(16)6.44%
Revenue beat(2)2
Avg Revenue beat(2)3.62%
Min Revenue beat(2)2.12%
Max Revenue beat(2)5.11%
Revenue beat(4)3
Avg Revenue beat(4)0.28%
Min Revenue beat(4)-6.26%
Max Revenue beat(4)5.11%
Revenue beat(8)4
Avg Revenue beat(8)-1.54%
Revenue beat(12)4
Avg Revenue beat(12)-4.62%
Revenue beat(16)5
Avg Revenue beat(16)-3.94%
PT rev (1m)0.7%
PT rev (3m)11.9%
EPS NQ rev (1m)-0.62%
EPS NQ rev (3m)0.77%
EPS NY rev (1m)-0.28%
EPS NY rev (3m)4.41%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)1.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.45%
Valuation
Industry RankSector Rank
PE 22.55
Fwd PE 18.38
P/S 2.19
P/FCF 26.13
P/OCF 20.24
P/B 1.62
P/tB N/A
EV/EBITDA 23
EPS(TTM)6.1
EY4.44%
EPS(NY)7.48
Fwd EY5.44%
FCF(TTM)5.26
FCFY3.83%
OCF(TTM)6.8
OCFY4.94%
SpS62.69
BVpS85.06
TBVpS-22.35
PEG (NY)1.27
PEG (5Y)43.55
Graham Number108.05
Profitability
Industry RankSector Rank
ROA -1.35%
ROE -2.5%
ROCE 2.39%
ROIC 1.95%
ROICexc 1.98%
ROICexgc 10.75%
OM 4.81%
PM (TTM) N/A
GM 35.8%
FCFM 8.4%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
ROICexc(3y)7.1%
ROICexc(5y)8.09%
ROICexgc(3y)24.27%
ROICexgc(5y)25.88%
ROCE(3y)6.33%
ROCE(5y)8.04%
ROICexgc growth 3Y-1.29%
ROICexgc growth 5Y-6.67%
ROICexc growth 3Y-5.85%
ROICexc growth 5Y-12.74%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.97
Debt/EBITDA 5.04
Cap/Depr 36%
Cap/Sales 2.45%
Interest Coverage 250
Cash Conversion 93.41%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.53
Altman-Z 1.85
F-Score3
WACC8.99%
ROIC/WACC0.22
Cap/Depr(3y)71.26%
Cap/Depr(5y)66.65%
Cap/Sales(3y)3.61%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.08%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%29.33%
EPS Next Y17.72%
EPS Next 2Y21.12%
EPS Next 3Y22.75%
EPS Next 5YN/A
Revenue 1Y (TTM)92.43%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%120.65%
Revenue Next Year113.32%
Revenue Next 2Y49.55%
Revenue Next 3Y33%
Revenue Next 5Y4.83%
EBIT growth 1Y-4.04%
EBIT growth 3Y-3.08%
EBIT growth 5Y-9.84%
EBIT Next Year194.36%
EBIT Next 3Y56.52%
EBIT Next 5YN/A
FCF growth 1Y328.68%
FCF growth 3Y4%
FCF growth 5Y22.04%
OCF growth 1Y167.78%
OCF growth 3Y1.15%
OCF growth 5Y16.21%

JBT MAREL CORP / JBTM FAQ

What is the fundamental rating for JBTM stock?

ChartMill assigns a fundamental rating of 3 / 10 to JBTM.


What is the valuation status for JBTM stock?

ChartMill assigns a valuation rating of 3 / 10 to JBT MAREL CORP (JBTM). This can be considered as Overvalued.


Can you provide the profitability details for JBT MAREL CORP?

JBT MAREL CORP (JBTM) has a profitability rating of 3 / 10.


What is the valuation of JBT MAREL CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for JBT MAREL CORP (JBTM) is 22.55 and the Price/Book (PB) ratio is 1.62.


What is the earnings growth outlook for JBT MAREL CORP?

The Earnings per Share (EPS) of JBT MAREL CORP (JBTM) is expected to grow by 17.72% in the next year.